Your browser doesn't support javascript.
loading
NLRC5/MHC class I transactivator: A key target for immune escape by SARS-CoV-2.
Zhu, Baohui; Ouda, Ryota; Kasuga, Yusuke; de Figueiredo, Paul; Kobayashi, Koichi S.
Afiliação
  • Zhu B; Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
  • Ouda R; Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
  • Kasuga Y; Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
  • de Figueiredo P; Christopher S Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
  • Kobayashi KS; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.
Bioessays ; 46(4): e2300109, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38461519
ABSTRACT
Antigen presentation to CD8+ T cells by MHC class I molecules is essential for host defense against viral infections. Various mechanisms have evolved in multiple viruses to escape immune surveillance and defense to support viral proliferation in host cells. Through in vitro SARS-CoV-2 infection studies and analysis of COVID-19 patient samples, we found that SARS-CoV-2 suppresses the induction of the MHC class I pathway by inhibiting the expression and function of NLRC5, a major transcriptional regulator of MHC class I genes. In this review, we discuss the molecular mechanisms for suppression of the MHC class I pathway and clinical implications for COVID-19.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genes MHC Classe I / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genes MHC Classe I / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article